His talk will focus on the practical aspects of harnessing the medical power of regenerative medicine and the incorporation of this modality into daily practice.
(PRWEB) September 26, 2017
Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc., will be speaking at this year’s Wild West Veterinary Conference in Reno, Nevada. Dr. Harman will be speaking on Friday, October 13th from 10:00 am to 11:30 am. His talk, “Stem Cells: Business Sense Today and Tomorrow” is sponsored by The Veterinary Cooperative. Dr. Harman is a frequent speaker on the topic of regenerative medicine at conferences around the country.
Dr. Harman has been a leader in the field of regenerative medicine for over a decade, he has presented on the topic at both human and animal conferences. He applies his biotechnology and veterinary experience in the clinical application of stem cell therapy for various types of injuries, illnesses, and other healing-promoting applications. Dr. Harman has also authored 13 peer-reviewed articles and book chapters.
In his talk, Dr. Harman will discuss the term “regenerative medicine” and the various applications that encompass this field of veterinary medicine. This will include a discussion of stem cell sources, and their commonality of use. His talk will focus on the practical aspects of harnessing the medical power of regenerative medicine and the incorporation of this modality into daily practice. He will analyze the current mega-trends in the veterinary profession that are driving the adoption of advanced cell therapies like stem cell therapy. These mega-trends include owners’ concerns about long-term use of prescription medications for their pets, the increase in the number of pet owners without children at home, and the expansion of the pet insurance market.
VetStem has been providing commercial adipose-derived stem cell therapy services to veterinarians for over 13 years with over 13,000 animals treated. They pioneered the use of regenerative stem cells in veterinary medicine and continue to advance the technology. The primary uses for stem cell therapy include osteoarthritis, tendon and ligament injuries, fractures, and muscle injury in the horse, dog and cat, but new research is leading to application in many internal medicine areas such as dry eye and gingival stomatitis.
VetStem Biopharma will be exhibiting at the Wild West Veterinary Conference exhibit hall from Thursday, October 12th through Saturday October 14th. Visit us at booth #300 for more information on stem cell therapy and other services.
About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-lead Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego (California), currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 15 years and 13,000 patients treated by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality beyond the realm of research. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. The Company’s stated mission being “to extend and enhance the lives of animals by improving the quality of recovery in acute conditions, but also by unlocking ways to slow, stop and ultimately revert the course of chronic diseases”. In addition to its’ own portfolio of patents, VetStem holds exclusive global veterinary licenses to a portfolio of over 70 issued patents in the field of regenerative medicine.